Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Leukemia, Myeloid, Acute 8Lymphoma 5Leukemia, Biphenotypic, Acute 5Leukemia 5Myelodysplastic Syndromes 4Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3Neoplasms 2Leukemia, Myeloid 2Leukemia, Monocytic, Acute 2Leukemia, Lymphoid 2Leukemia, Lymphocytic, Chronic, B-Cell 2Leukemia, B-Cell 2Hematologic Neoplasms 2Hematologic Diseases 2Burkitt Lymphoma 2Anemia, Refractory, with Excess of Blasts 2Shwachman-Diamond Syndrome 1Preleukemia 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precancerous Conditions 1Neoplasms by Histologic Type 1Myeloproliferative Disorders 1Lymphoproliferative Disorders 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Primary Effusion 1Lymphoma, Non-Hodgkin 1Lymphatic Diseases 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myelomonocytic, Acute 1

Interventions

aldesleukin 1Whole-Body Irradiation 1Peripheral Blood Stem Cell Transplantation 1Idarubicin 1Filgrastim 1Etoposide 1Cytarabine 1Busulfan 1Bone Marrow Transplantation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leukemia, Eosinophilic, Acute × Bone Marrow Transplantation × 1 year × Clear all
NCT00534469 2025-12-02

Auto BMT for Non-M3 AML in 1st Remission in Pts </=60y of Age Using Busulfan/FTBI & VP16 as a Prep R

City of Hope Medical Center

Phase 2 Completed
60 enrolled 9 charts
Other hematologic neoplasm

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Basophilic, Acute, Leukemia, Eosinophilic, Acute, Leukemia, Myelomonocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡